Pharmaceutical Care of Patients with Acnetic Dermatitis in the context of Active Ingredients

----------------------

Elena Mospanova, Ph.D., associate professor, practicing cosmetologist, author of more than 90 scientific articles, 10 Ukrainian patents for an invention, founder of EDENA

--------------------------

 

Even a cursory review of the market for oily skin cosmetics in search engines, we can conclude that the race of marketing strategies is gaining momentum. Every second cosmetic product promises miraculous results in a short time. The number of products on popular marketplaces for the query “oily skin product” has more than one thousand offers.

Of course, it is not possible for a patient to deal with so many cosmetic products on the market on his own. What can we say about efficiency? And the unequivocal conclusion suggests itself that in the race of marketing strategies, the patient suffers. The visit to the doctor is delayed, the prognosis worsens, the patient loses money and time.

 Therefore, dermatologists, aesthetic medicine specialists, and pharmacists need to focus on conveying truthful information to the patient. That is, to implement pharmaceutical care - to promote the rational use of both over-the-counter drugs and cosmetics.

So, acne is a chronic inflammatory dermatosis, which consists of:

• open comedones;
• closed comedones;
• papules;
• pustules;
• cysts;
• knots.

Acne patients make up a high percentage of cosmetic appointments and it is almost impossible to prevent the appearance of acne. That is, at a certain point, acne elements appear and most often this is due to:

• genetic predisposition;
• anatomical structure of the sebaceous gland;
• increased sebum production against the background of hyperandrogenism;
• hyperkeratosis;
• formation of microcomedone;
• biochemical factor, changes in the chemical composition of sebum;
• activation of C. acne;
• immune factor, development of inflammation.

 

*Full version of the access article in Ukrainian and Russian